医学
心房颤动
内科学
心力衰竭
心脏病学
冲程(发动机)
射血分数
导管消融
机械工程
工程类
作者
Taiji Okada,Takeshi Kitai,Atsushi Kobori,Madoka Sano,Ryosuke Murai,Toshiaki Toyota,Yasuhiro Sasaki,Tomohiko Taniguchi,Kitae Kim,Natsuhiko Ehara,Makoto Kinoshita,Yutaka Furukawa
出处
期刊:Open heart
[BMJ]
日期:2024-01-01
卷期号:11 (1): e002526-e002526
被引量:4
标识
DOI:10.1136/openhrt-2023-002526
摘要
BACKGROUND: The Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology (HFA-PEFF) score has been developed for diagnosing heart failure with preserved ejection fraction (HFpEF), which is frequently associated with atrial fibrillation (AF). We aimed to investigate whether preprocedural HFA-PEFF score could be used to predict clinical outcomes in patients with AF who underwent catheter ablation (CA). METHODS: Overall, 1679 patients with AF who underwent primary CA (71±10 years, 1218 males (72.5%), median follow-up duration 3.3 years) from July 2011 to December 2019 were included in this retrospective study. HFpEF was defined as an HFA-PEFF score ≥5. The primary study outcome was 5-year major adverse cardiovascular and cerebrovascular events (MACCE), which is a composite of all-cause death, hospitalisation for heart failure (HF) and hospitalisation for stroke. RESULTS: scoring. Five-year MACCE occurred in 77 patients (4.6%). The cumulative 5-year incidence of MACCE was significantly higher in the HFpEF group than in the non-HFpEF group (11.2% vs 4.8% at 5 years, p<0.001). In the multivariable analysis, HFpEF by the HFA-PEFF score was associated with MACCE (adjusted HR 1.65, 95% CI 1.02 to 2.65, p=0.041). CONCLUSIONS: Early detection of HFpEF using the HFA-PEFF score may have clinical applications in guiding therapeutic decision-making and improving prognosis by preventing HF and stroke in patients with AF undergoing CA.
科研通智能强力驱动
Strongly Powered by AbleSci AI